Eli Lilly stock climbed around 6 percent after robust second quarter results. On August 19, company shares moved up by 5.18 percent to reach an all-time high of 1249.95 USD. Industry coverage from Yahoo Finance, Investing.com, and TradingKey examined the factors behind the quick climb in stock price.
Reports from 24/7 Wall St. and Kalkine Media reviewed outlook for Eli Lilly, including a next 1 trillion opportunity for the pharmaceutical firm. More commentary zeroed in on whether the company valuation story is improving in the wake of the record trading session.